Cytologic changes in hepatocellular carcinoma after percutaneous acetic acid injection -: Correlation with helical computed tomography findings

被引:6
作者
Lin, SM
Kuo, SH
Lin, DY
Lin, CJ
Shen, CH
Hung, CF
机构
[1] Chang Gung Univ, Liver Res Unit, Taipei 105, Taiwan
[2] Chang Gung Mem Hosp, Liver Res Unit, Taipei 10591, Taiwan
[3] Chang Gung Mem Hosp, Dept Diagnost Radiol 1, Taipei 10591, Taiwan
[4] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan
关键词
hepatocellular carcinoma; tomography; x-ray computed; acetic acid; percutaneous administration; helical computed tomography;
D O I
10.1159/000326215
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
OBJECTIVE: To illustrate the cytologic features of hepatocellular carcinoma (HCC) after percutaneous acetic acid injection (PAI) and to correlate the cytologic findings with helical computed tomography (CT)findings. STUDY DESIGN: The study included 30 patients with 37 HCC who had undergone PAI. Baseline cytomorphology of HCC was evaluated by needle aspiration in all cases. PAI tinder ultrasound guidance was done every three to seven days. Upon completion of PAI, fine needle aspiration cytology was performed and followed by helical CT within two weeks. The degeneration of HCC after PAI was classified into two grades. Grade 1 showed incomplete degeneration (99% of nuclear area); grade 2 showed complete degeneration or severe degeneration with cell debris or amorphous material only. The specimens were stained with Riu's method (Romanowsky system). RESULTS: The cytologic changes after PAI included decreased cell number, reduced cellular aggregation, degeneration of cytoplasm and nucleus, and eosinophilic or basophilic background in all tumors. In all the 37 tumors without enhancement on helical CT, grade 2 degeneration was detected. CONCLUSION: Our results reveal that grade 2 degeneration alone, demonstrated cytologically, could indicate almost complete necrosis of HCC after PAI, probably implying no need for booster PAI.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 29 条
[1]  
[Anonymous], 1956, J NIGADA MED ASS
[2]  
ARII S, 1992, PRIMARY LIVER CANC J, P243
[3]   HEPATOCELLULAR-CARCINOMA - CT AND MR FEATURES AFTER TRANSCATHETER ARTERIAL EMBOLIZATION AND PERCUTANEOUS ETHANOL INJECTION [J].
BARTOLOZZI, C ;
LENCIONI, R ;
CARAMELLA, D ;
FALASCHI, F ;
CIONI, R ;
DICOSCIO, G .
RADIOLOGY, 1994, 191 (01) :123-128
[4]  
CASTELLS A, 1993, HEPATOLOGY, V18, P1121
[5]  
CHEN MF, 1989, ARCH SURG-CHICAGO, V124, P1025
[6]   PERCUTANEOUS ETHANOL INJECTION FOR THE TREATMENT OF SMALL HEPATOCELLULAR-CARCINOMA - STUDY OF 95 PATIENTS [J].
EBARA, M ;
OHTO, M ;
SUGIURA, N ;
KITA, K ;
YOSHIKAWA, M ;
OKUDA, K ;
KONDO, F ;
KONDO, Y .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1990, 5 (06) :616-626
[7]   DIAGNOSIS OF SMALL HEPATOCELLULAR-CARCINOMA - CORRELATION OF MR IMAGING AND TUMOR HISTOLOGIC-STUDIES [J].
EBARA, M ;
OHTO, M ;
WATANABE, Y ;
KIMURA, K ;
SAISHO, H ;
TSUCHIYA, Y ;
OKUDA, K ;
ARIMIZU, N ;
KONDO, F ;
IKEHIRA, H ;
FUKUDA, N ;
TATENO, Y .
RADIOLOGY, 1986, 159 (02) :371-377
[8]   HEPATOCELLULAR-CARCINOMA NOT DETECTED WITH PLAIN US - TREATMENT WITH PERCUTANEOUS ETHANOL INJECTION UNDER GUIDANCE WITH ENHANCED US [J].
IMARI, Y ;
SAKAMOTO, S ;
SHIOMICHI, S ;
ISOBE, H ;
IKEDA, M ;
SATOH, M ;
NAWATA, H .
RADIOLOGY, 1992, 185 (02) :497-500
[9]   HEPATOCELLULAR-CARCINOMA - CT APPEARANCE AFTER PERCUTANEOUS ETHANOL ABLATION THERAPY - WORK IN PROGRESS [J].
JOSEPH, FB ;
BAUMGARTEN, DA ;
BERNARDINO, ME .
RADIOLOGY, 1993, 186 (02) :553-556
[10]  
KOTOH K, 1994, AM J GASTROENTEROL, V89, P194